Approximately 70% of DBA patients possess a mutation in one of 19 genes that encode ribosomal proteins, with mutations in Ribosomal Protein S19 (RPS19) accounting for over 25% and RPL11 comprising ~5% of cases. Here, RPL11 is linked to Diamond-Blackfan anemia.